Vitamin D and Cancer

Share this content:
There is not enough evidence to conclude that vitamin D dietary supplements are an effective intervention for reducing cancer risk or improving cancer outcomes.
There is not enough evidence to conclude that vitamin D dietary supplements are an effective intervention for reducing cancer risk or improving cancer outcomes.

General Information

Vitamin D is a family of prohormones involved in calcium and phosphorus metabolism; it is also directly involved in bone health. The most common isoforms are ergocalciferol (D2), which is found in plants, and cholecalciferol (D3), which is produced by human skin with UV sunlight exposure.1,2 Blood levels reflect exposure to sunlight, skin pigmentation, and dietary intake, among other factors.

The recommended daily dietary allowance for vitamin D is 15 μg (600 International Units [IUs]) for people aged 1 to 70 years and 20 μg (800 IU) daily after age 70 years.3,4 Dietary sources include fish, eggs, fortified cow's milk, and fruit juice; vitamin D dietary supplements can also be purchased over the counter.

Epidemiological research suggests that cancer mortality might be higher in northern latitudes where people tend to experience less sun exposure, and hence, lower levels of vitamin-production in the skin, sparking interest in a possible connection between vitamin D and cancer risk and outcomes. Preclinical studies suggest possible biological mechanisms for a relationship between vitamin D and tumor growth, including cancer cell inhibition, anti-inflammatory and antiangiogenic effects in vitro, and promotion of apoptosis — bolstering interest in a possible connection.

Exaggerated claims about the evidence base and known anticancer benefits of vitamin D are, however, widespread online. A number of clinical studies were recently undertaken to scientifically assess the potential roles of vitamin D intake and circulating levels of 25(OH)D (the biologically active prehormone formed by the liver's hydroxylation of cholecalciferol) with cancer risk and cancer outcomes.

Page 1 of 3

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters